Loading...
Loading...
Loading...
Loading...
Atlas Antibodies


![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human Cerebral Cortex tissue](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19509/15859/atl-amab91062_anti-mbp-mab-clone-cl2819-atl-amab91062_26437__71883.1783621297.jpg?compression=lossy)


![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human Cerebral Cortex tissue](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19509/15859/atl-amab91062_anti-mbp-mab-clone-cl2819-atl-amab91062_26437__71883.1783621297.jpg?compression=lossy)
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human, Mouse, Rat |
| Clonality | Monoclonal IgG2a (Clone No.: CL2819) |
| Host | Mouse |
| Gene ID - Mouse | ENSMUSG00000041607 |
| Gene ID - Rat | ENSRNOG00000016516 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) | |
| Datasheet | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) Datasheet (External Link) |
| Vendor Page | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) at Atlas Antibodies |
| Documents & Links for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) | |
| Datasheet | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) Datasheet (External Link) |
| Vendor Page | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) |
| Citations for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) – 2 Found |
| Wang, Chen; Chi, Jingwei; Che, Kui; Ma, Xiaolong; Qiu, Mingyue; Wang, Zhongchao; Wang, Yangang. The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy. Experimental And Therapeutic Medicine. 2019;17(5):3555-3563. PubMed |
| Pandit, Kunal; Petrescu, Joana; Cuevas, Miguel; Stephenson, William; Smibert, Peter; Phatnani, Hemali; Maniatis, Silas. An open source toolkit for repurposing Illumina sequencing systems as versatile fluidics and imaging platforms. Scientific Reports. 2022;12(1):5081. PubMed |
No reviews have been added for this product.
Try browsing our complete catalog of products.
Atlas Antibodies


![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human Cerebral Cortex tissue](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19509/15859/atl-amab91062_anti-mbp-mab-clone-cl2819-atl-amab91062_26437__71883.1783621297.jpg?compression=lossy)


![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human Cerebral Cortex tissue](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/19509/15859/atl-amab91062_anti-mbp-mab-clone-cl2819-atl-amab91062_26437__71883.1783621297.jpg?compression=lossy)
| Product Specifications | |
| Application | WB, ICC, IHC |
| Reactivity | Human, Mouse, Rat |
| Clonality | Monoclonal IgG2a (Clone No.: CL2819) |
| Host | Mouse |
| Gene ID - Mouse | ENSMUSG00000041607 |
| Gene ID - Rat | ENSRNOG00000016516 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) | |
| Datasheet | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) Datasheet (External Link) |
| Vendor Page | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) at Atlas Antibodies |
| Documents & Links for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) | |
| Datasheet | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) Datasheet (External Link) |
| Vendor Page | Anti MBP mAb (Clone CL2819, ATL-AMAb91062) |
| Citations for Anti MBP mAb (Clone CL2819, ATL-AMAb91062) – 2 Found |
| Wang, Chen; Chi, Jingwei; Che, Kui; Ma, Xiaolong; Qiu, Mingyue; Wang, Zhongchao; Wang, Yangang. The combined effect of mesenchymal stem cells and resveratrol on type 1 diabetic neuropathy. Experimental And Therapeutic Medicine. 2019;17(5):3555-3563. PubMed |
| Pandit, Kunal; Petrescu, Joana; Cuevas, Miguel; Stephenson, William; Smibert, Peter; Phatnani, Hemali; Maniatis, Silas. An open source toolkit for repurposing Illumina sequencing systems as versatile fluidics and imaging platforms. Scientific Reports. 2022;12(1):5081. PubMed |